Tag

Tag: Germany

centogene rare diseases diagnostic ipo nasdaq

07/11/2019 1 min

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

Biotech companies Munich

04/11/2019 4 mins

Top 10 Biotech Companies Leaving a Mark in Munich

alzheimer's disease treatment vivoryon therapeutics

24/10/2019 2 mins

German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround

BioNTech Nasdaq IPO

10/10/2019 2 mins

Update: BioNTech Files for €141M Nasdaq IPO

cancer treatment tacalyx

25/09/2019 2 mins

German Biotech Will Develop Carbohydrate-Targeting Cancer Treatments

grunenthal mesoblast chronic low back pain

11/09/2019 2 mins

Grünenthal to Pay up to €900M for Chronic Low Back Pain Cell Therapy

celgene immatics cancer cell immunotherapy

28/08/2019 2 mins

Celgene and Immatics Sign Deal Worth Over €1.35B to Develop Cancer Immunotherapies

colorectal cancer mologen cancer immunotherapy

06/08/2019 2 mins

German Cancer Immunotherapy Flops in Phase III

acute respiratory distress syndrome pantherna berlin inflammatory disease

02/08/2019 3 mins

This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation

Wellington Partners life science fund

31/07/2019 2 mins

Wellington Partners Raises €210M to Invest in European Life Sciences

popcorn lung breath therapeutics zambon

25/07/2019 1 min

German Biotech Breath Therapeutics Acquired in Deal Worth up to €500M

boehringer ingelheim cancer vaccine amal therapeutics

16/07/2019 1 min

Boehringer Ingelheim Acquires Cancer Vaccine Biotech in €325M Deal

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.